Innovation Pharmaceuticals Inc (IPIX)

[macnqueso]

The Aspire deal is to give Leo time to do what needs to be done to secure a good deal for Brilacidin...

Here is one problem with Brilacidin... deep pocketed players have actually disbanded their anti-biotic programs for the most part... which is one of the reasons CTIX was able to sneak in and get it on the cheap... now imagine you work for one of these deep-pocketed players and with the GAIN act and the promise of Brilacidin... has the financial equation changed such that you want to get back in... maybe... probably not... and even if you do are you now willing to pay a significant mulitple over what you could have just acquired by buying Polymedix only a short time before... how do you explain that one to the execs and shareholders you answer to... we didn't think it was worth acquiring Polymedix for this, but we are now willing to pay 10 or 20 times that to acquire licensing rights to its lead candidate... doesn't make you look to sharp does it...

so for a deep-pocketed player to save face they will require a completed phase 2b with data in order to say... ok now more of the risk is removed... we were being careful, but now the dynamics have changed...

Leo will need to complete a phase 2b to get the return he wants on Brilacidin... that is why the Aspire financing agreement is important...